Dieter Kabelitz, M.D.

Professor at the University of Kiel, Director of the Institute of Immunology

His scientific expertise is in the field of the functional characterization of human T cells with a special focus on γδ T cells. Current projects aim to explore the potential of human γδ T cells for the immunotherapy of cancer. From 1992 to 1999 he was Head of the Department of Immunology at the Paul-Ehrlich Institute in Langen, Germany. Previously, he was Associate Professor for Cellular Immunology at the University of Heidelberg. Dr. Kabelitz studied medicine in Freiburg and Munich, Germany, and was a post-doc in Uppsala, Sweden and at The Rockefeller University in New York. Dr. Kabelitz was chairman of the Collaborative Research Center (SFB) 415 “Specificity and Pathophysiology of Signal Transduction Pathways”  funded at Kiel University by the German Research Foundation (DFG).  He is a founding member and member of the Steering Committee of the DFG-funded Cluster of Excellence “Inflammation-at-Interfaces”.  He was President of the German Society for Immunology (DGfI) in 2011 and 2012, and he is a Council member of the International Union of Immunological Societies (IUIS) and active in the Education Committee (EDU) of IUIS.